Alberto Sanchez-Fueyo
MD
Dr. Sánchez-Fueyo received his MD from the University of Barcelona, Spain in 1993. Following a residency in Gastroenterology and Hepatology at the Hospital Clinic Barcelona, he received his PhD from the University of Barcelona in 2000. From 2000 to 2004, Dr. Sánchez-Fueyo received post-doctoral training in Transplant Immunology at the Beth Israel Deaconess Medical Center, Harvard Medical School, USA, in the laboratory of Dr Terry B. Strom. Since 2004 he is a faculty member at the Liver Transplant Unit at the Hospital Clinic Barcelona/IDIBAPS (University of Barcelona), and directs the Liver Trasplant Immunology Lab, which is focused on the study of the immunological aspects of human liver transplantation with an emphasis in the use of high-throughput genomic technologies. Current major lines of research are the characterization of operationally tolerant liver transplant recipients, the search for biomarkers predictive of tolerance development, and the study of anti-hepatitis C virus immune responses in liver transplant recipients. These studies have recently resulted in the discovery of several novel transcriptional biomarkers of operational tolerance in liver transplantation (reported in J Clin Invest 2008; 118(8):2845-2857). Among his additional professional responsabilities, Dr Sánchez-Fueyo is currently a member of the scientific advisory board of the Roche Organ Transplantation Research Foundation (ROTRF) and has recently been appointed Associate Editor at American Journal of Transplantation.